Clinical Mismatch

Here is what it looks like: a patient receives a drug for a body system for which they have no recorded diagnosis. This is not a drug interaction or incorrect dose — the medication simply does not correspond to any documented condition of the patient.

In an analysis of Latin American health insurance claims, 1 in 6 subscribers received a drug with no diagnostic justification. 80% of these cases were for the wrong body system entirely — not minor variations, but fundamental therapeutic incompatibilities.

These mismatches can indicate negligent prescribing, dispensing without diagnostic validation, or system abuse where high-value medications are prescribed without real medical need. In all cases, the insurer pays for treatments that may not benefit the patient.

At the same time, it is crucial to recognize legitimate clinical exceptions. Patients with complex conditions such as oncology, HIV, cardio-metabolic, or neurology frequently require multiple medications that might appear unjustified in a superficial analysis.

Clinical mismatches represent a significant cost: $22 median per dispense, with an annual projection of $126K per 50,000 subscribers. But the impact goes beyond cost — these mismatches raise questions about care quality and patient safety.

Every drug dispensed without diagnostic justification is a missed opportunity to intervene. Whether it is a prescribing error, an undocumented diagnosis, or deliberate system abuse, early detection allows clinical teams to evaluate and act before the pattern repeats.